Targeting HIV: Past, Present and Future

Author(s): Michele D. Zeier, Jean B. Nachega

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders

Volume 11 , Issue 2 , 2011

Become EABM
Become Reviewer
Call for Editor


Since the identification of the Human Immunodeficiency Virus (HIV) as the cause of the syndrome of Acquired Immunodeficiency Syndrome (AIDS), there has been an evolution of compounds targeting the replication of the virus in an effort to delay clinical progression. In this review, we revise the mechanism of action of the different groups of drugs. We shortly revisit the older and perhaps lesser used as well as the more recently approved drugs and mention some of the compounds still under investigation.

Keywords: Antiretroviral, HIV, review, targets, therapy, AIDS, the mechanism of action of the different groups of drugs, compounds, viral targets, envelope protein, gp120, chemokine co-receptor, immunosuppression, reverse transcriptase, protease inhibitors, apoptosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [98 - 114]
Pages: 17
DOI: 10.2174/187152611795589690
Price: $65

Article Metrics

PDF: 8